Virchows Archiv

, Volume 474, Issue 2, pp 259–264 | Cite as

Gastrointestinal juvenile-like (inflammatory/hyperplastic) mucosal polyps in neurofibromatosis type 1 with no concurrent genetic or clinical evidence of other syndromes

  • Gloria Ravegnini
  • Giuseppe Quero
  • Giulia Sammarini
  • Maria Cristina Giustiniani
  • Federica Castri
  • Maria Grazia Pomponi
  • Sabrina Angelini
  • Sergio Alfieri
  • Maurizio Genuardi
  • Giuseppe Zamboni
  • Riccardo RicciEmail author
Brief Report


Gastrointestinal “juvenile-like (inflammatory/hyperplastic) mucosal polyps” (JLIHMPs) have been proposed as a neurofibromatosis type 1 (NF1)-specific gastrointestinal manifestation. Juvenile polyposis syndrome (JPS) has also been reported in a NF1 patient, harboring concurrent NF1 and SMAD4 germline mutations. Additionally, NF1-like cafe-au-lait spots have been described in biallelic mismatch repair deficiency, another condition featuring gastrointestinal polyps. The SMAD4 and BMPR1A genes that are involved in 50–60% of JPS cases have not been investigated in the ~ 20 published cases of NF1-associated JLIHMPs with the exception of the abovementioned patient with concomitant JPS and NF1. NF1 defects have been found in the only two cases exhaustively tested. Therefore, JLIHMP has been questioned as an independent, NF1-specific entity. Incidental associations between NF1 and gastrointestinal polyposes at risk for gastrointestinal carcinoma should not be overlooked, given their implications in terms of clinical surveillance. We describe two patients featuring JLIHMPs in clinically/genetically proven NF1, in the absence of SMAD4 and BMPR1A mutations. In one case, the intervening mucosa was markedly inflamed, unlike JPS. We suggest that JLIHMP probably represents a gastrointestinal lesion specific to NF1.


Hyperplastic polyp Inflammatory polyp Juvenile polyp Molecular diagnosis Neurofibromatosis von Recklinghausen disease 



We are grateful for our patients’ generosity in participating in this research.


RR conceived and designed the study and wrote the manuscript; GR and GS performed DNA Sanger sequencing; MGP and MG performed MLPA analysis; GQ, SeA, and GZ collected clinical data; GQ and SeA performed surgery; GR, MCG, FC, MGP, SaA, MG, GZ, and RR analyzed data. All authors critically reviewed the manuscript and gave final approval for publication.


This work was supported by the Università Cattolica del Sacro Cuore (Linea D1 grant number R4124500212 to RR). Gloria Ravegnini is supported by a MSD Italia fellowship granted by and on behalf of Merck Sharp & Dohme Corporation.

Compliance with ethical standards

Informed consent was obtained from all individual participants included in the study. All procedures performed were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Conflict of interest

The authors declare that they have no conflict of interest.


  1. 1.
    Agaimy A, Vassos N, Croner RS (2012) Gastrointestinal manifestations of neurofibromatosis type 1 (Recklinghausen’s disease): clinicopathological spectrum with pathogenetic considerations. Int J Clin Exp Pathol 5:852–862PubMedPubMedCentralGoogle Scholar
  2. 2.
    Agaimy A, Schaefer IM, Kotzina L, Knolle J, Baumann I, Strobel P, Vieth M (2014) Juvenile-like (inflammatory/hyperplastic) mucosal polyps of the gastrointestinal tract in neurofibromatosis type 1. Histopathology 64:777–786CrossRefPubMedGoogle Scholar
  3. 3.
    Baratelli F, Le M, Gershman GB, French SW (2014) Do mast cells play a pathogenetic role in neurofibromatosis type 1 and ulcerative colitis? Exp Mol Pathol 96:230–234CrossRefPubMedGoogle Scholar
  4. 4.
    Brosens LA, Offerhaus GJ, Canto MI, Montgomery EA, Giardiello FM (2016) Simultaneous juvenile polyposis syndrome and neurofibromatosis type 1. Histopathology 68:313–315CrossRefPubMedGoogle Scholar
  5. 5.
    Goto K, Hirosaki T, Masubuchi M (2017) Neurofibromatosis type 1-associated inflammatory polyp of the gastrointestinal tract. Int J Surg Pathol 25:65–68CrossRefPubMedGoogle Scholar
  6. 6.
    Aijaz N, Draganov P, Iqbal A, Liu X (2017) Coexistence of juvenile-like polyp with neurofibroma at the gastroesophageal junction in an adult with neurofibromatosis type I. Case Rep Pathol 2017:9836759PubMedPubMedCentralGoogle Scholar
  7. 7.
    Durno CA, Sherman PM, Aronson M, Malkin D, Hawkins C, Bakry D, Bouffet E, Gallinger S, Pollett A, Campbell B, Tabori U, International BC (2015) Phenotypic and genotypic characterisation of biallelic mismatch repair deficiency (BMMR-D) syndrome. Eur J Cancer 51:977–983CrossRefPubMedGoogle Scholar
  8. 8.
    van Hattem WA, Brosens LA, de Leng WW, Morsink FH, Lens S, Carvalho R, Giardiello FM, Offerhaus GJ (2008) Large genomic deletions of SMAD4, BMPR1A and PTEN in juvenile polyposis. Gut 57:623–627CrossRefPubMedGoogle Scholar
  9. 9.
    Ricci R (2016) Syndromic gastrointestinal stromal tumors. Hered Cancer Clin Pract 14:15CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Montgomery E, Voltaggio L (2018) Biopsy interpretation of the gastrointestinal tract mucosa. Wolters Kluwer, PhiladelphiaGoogle Scholar
  11. 11.
    Ricci R, Martini M, Cenci T, Carbone A, Lanza P, Biondi A, Rindi G, Cassano A, Larghi A, Persiani R, Larocca LM (2015) PDGFRA-mutant syndrome. Mod Pathol 28:954–964CrossRefPubMedGoogle Scholar
  12. 12.
    Schildhaus HU, Cavlar T, Binot E, Buttner R, Wardelmann E, Merkelbach-Bruse S (2008) Inflammatory fibroid polyps harbour mutations in the platelet-derived growth factor receptor alpha (PDGFRA) gene. J Pathol 216:176–182CrossRefPubMedGoogle Scholar
  13. 13.
    Staser K, Yang FC, Clapp DW (2010) Plexiform neurofibroma genesis: questions of Nf1 gene dose and hyperactive mast cells. Curr Opin Hematol 17:287–293CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    He SH (2004) Key role of mast cells and their major secretory products in inflammatory bowel disease. World J Gastroenterol 10:309–318CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Tavakkoli H, Asadi M, Mahzouni P, Foroozmehr A (2009) Ulcerative colitis and neurofibromatosis type 1 with bilateral psoas muscle neurofibromas: a case report. J Res Med Sci 14:261–265PubMedPubMedCentralGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  • Gloria Ravegnini
    • 1
  • Giuseppe Quero
    • 2
  • Giulia Sammarini
    • 1
  • Maria Cristina Giustiniani
    • 3
  • Federica Castri
    • 3
  • Maria Grazia Pomponi
    • 4
  • Sabrina Angelini
    • 1
  • Sergio Alfieri
    • 2
    • 5
  • Maurizio Genuardi
    • 4
    • 6
  • Giuseppe Zamboni
    • 7
  • Riccardo Ricci
    • 3
    • 8
    Email author
  1. 1.Dipartimento di Farmacia e BiotecnologieUniversità di BolognaBolognaItaly
  2. 2.UOC di Chirurgia DigestivaFondazione Policlinico Universitario “A. Gemelli” IRCCSRomeItaly
  3. 3.UOC di Anatomia PatologicaFondazione Policlinico Universitario “A. Gemelli” IRCCSRomeItaly
  4. 4.UOC di Genetica MedicaFondazione Policlinico Universitario “A. Gemelli” IRCCSRomeItaly
  5. 5.Dipartimento di Scienze ChirurgicheUniversità Cattolica del Sacro CuoreRomeItaly
  6. 6.Istituto di Medicina GenomicaUniversità Cattolica del Sacro CuoreRomeItaly
  7. 7.Department of Diagnostics and Public Health-Section of PathologyUniversity of Verona, IRCCS Sacro Cuore Don Calabria HospitalNegrar, VeronaItaly
  8. 8.Istituto di Anatomia PatologicaUniversità Cattolica del Sacro CuoreRomeItaly

Personalised recommendations